38 results
PRE 14A
HARP
Harpoon Therapeutics Inc
14 Apr 23
Preliminary proxy
4:54pm
: Gender Identity
Directors
Part II: Demographic Background
African American or Black
Alaskan Native or Native American
Asian
Hispanic or Latinx … calculated based on the Black-Scholes option valuation methodology equal to the annual cash compensation the election option is granted in lieu
8-K
EX-99.3
18zbnl8ww5x9k x5pt
4 Jun 21
Harpoon Therapeutics Presents Updated Interim Clinical Data for the PSMA-targeting TriTAC® HPN424 at the 2021 ASCO Annual Meeting
4:40pm
8-K
EX-99.2
eoo fq39h
9 Dec 20
Harpoon Therapeutics Reports Clinical Progress Across All Four TriTAC® Pipeline Development Programs
4:52pm